<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35842587</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1689-1392</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>Cellular &amp; molecular biology letters</Title><ISOAbbreviation>Cell Mol Biol Lett</ISOAbbreviation></Journal><ArticleTitle>Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects.</ArticleTitle><Pagination><StartPage>56</StartPage><MedlinePgn>56</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">56</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s11658-022-00359-z</ELocationID><Abstract><AbstractText>Recently, mesenchymal stromal cell (MSC)-based therapy has become an appreciated therapeutic approach in the context of neurodegenerative disease therapy. Accordingly, a myriad of studies in animal models and also some clinical trials have evinced the safety, feasibility, and efficacy of MSC transplantation in neurodegenerative conditions, most importantly in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). The MSC-mediated desired effect is mainly a result of secretion of immunomodulatory factors in association with release of various neurotrophic factors (NTFs), such as glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF). Thanks to the secretion of protein-degrading molecules, MSC therapy mainly brings about the degradation of pathogenic protein aggregates, which is a typical appearance of chronic neurodegenerative disease. Such molecules, in turn, diminish neuroinflammation and simultaneously enable neuroprotection, thereby alleviating disease pathological symptoms and leading to cognitive and functional recovery. Also, MSC differentiation into neural-like cells in&#xa0;vivo has partially been evidenced. Herein, we focus on the therapeutic merits of MSCs and also their derivative exosome as an innovative cell-free approach in AD, HD, PD, and ALS conditions. Also, we give a brief glimpse into novel approaches to potentiate MSC-induced therapeutic merits in such disorders, most importantly, administration of preconditioned MSCs.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahbaran</LastName><ForeName>Mohaddeseh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biotechnology Department, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zekiy</LastName><ForeName>Angelina Olegovna</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Prosthetic Dentistry, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahramali</LastName><ForeName>Mahta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biotechnology Department, University of Tehran, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahangir</LastName><ForeName>Mohammadsaleh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mardasi</LastName><ForeName>Mahsa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biotechnology Department, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakhaei</LastName><ForeName>Delaram</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, Sari Branch, Islamic Azad University, Sari, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangavelu</LastName><ForeName>Lakshmi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shomali</LastName><ForeName>Navid</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamani</LastName><ForeName>Majid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, Faculty of Allied Medicine, Infectious Diseases Research Center, Gonabad University of Medical Sciences, Gonabad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran. Alimohammadi.neuro@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahnama</LastName><ForeName>Negin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Health Services, Semnan University of Medical Sciences, Semnan, Iran. rahnamanegin049@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Mol Biol Lett</MedlineTA><NlmUniqueID>9607427</NlmUniqueID><ISSNLinking>1425-8153</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045164" MajorTopicYN="Y">Mesenchymal Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="Y">Mesenchymal Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Differentiation</Keyword><Keyword MajorTopicYN="N">Mesenchymal stromal cells (MSCs)</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Neuroprotection</Keyword><Keyword MajorTopicYN="N">Neurotrophic factors (NTFs)</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35842587</ArticleId><ArticleId IdType="pmc">PMC9287902</ArticleId><ArticleId IdType="doi">10.1186/s11658-022-00359-z</ArticleId><ArticleId IdType="pii">10.1186/s11658-022-00359-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7):a028035. doi: 10.1101/cshperspect.a028035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028035</ArticleId><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Checkoway H, Lundin JI, Kelada SN. Neurodegenerative diseases. IARC Sci Publ. 2011;163:407&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">22997874</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs GG. Concepts and classification of neurodegenerative diseases. In: Handbook of clinical neurology. New York: Elsevier; 2018. p. 301&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28987178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, Manshouri S, Heidari F, Pornour M, Khoshmirsafa M, et al. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Cell Mol Biol Lett. 2022;27(1):10. doi: 10.1186/s11658-022-00311-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-022-00311-1</ArticleId><ArticleId IdType="pmc">PMC8809072</ArticleId><ArticleId IdType="pubmed">35109786</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discovery. 2004;3(3):205&#x2013;214. doi: 10.1038/nrd1330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1330</ArticleId><ArticleId IdType="pubmed">15031734</ArticleId></ArticleIdList></Reference><Reference><Citation>Amor S, Puentes F, Baker D, Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129(2):154&#x2013;169. doi: 10.1111/j.1365-2567.2009.03225.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2009.03225.x</ArticleId><ArticleId IdType="pmc">PMC2814458</ArticleId><ArticleId IdType="pubmed">20561356</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995;38(3):357&#x2013;366. doi: 10.1002/ana.410380304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380304</ArticleId><ArticleId IdType="pubmed">7668820</ArticleId></ArticleIdList></Reference><Reference><Citation>Dur&#xe3;es F, Pinto M, Sousa E. Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals. 2018;11(2):44. doi: 10.3390/ph11020044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph11020044</ArticleId><ArticleId IdType="pmc">PMC6027455</ArticleId><ArticleId IdType="pubmed">29751602</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakthiswary R, Raymond AA. Stem cell therapy in neurodegenerative diseases: from principles to practice. Neural Regen Res. 2012;7(23):1822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302533</ArticleId><ArticleId IdType="pubmed">25624807</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunn JS, Sakowski SA, Hur J, Feldman EL. Stem cell technology for neurodegenerative diseases. Ann Neurol. 2011;70(3):353&#x2013;361. doi: 10.1002/ana.22487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22487</ArticleId><ArticleId IdType="pmc">PMC3177143</ArticleId><ArticleId IdType="pubmed">21905078</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrente Y, Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant. 2008;17(10&#x2013;11):1103&#x2013;1113. doi: 10.3727/096368908787236576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368908787236576</ArticleId><ArticleId IdType="pubmed">19181205</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wang S, Cao W. Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases. Cell Immunol. 2018;326:8&#x2013;14. doi: 10.1016/j.cellimm.2017.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2017.06.006</ArticleId><ArticleId IdType="pubmed">28778534</ArticleId></ArticleIdList></Reference><Reference><Citation>Witkowska-Zimny M, Wrobel E. Perinatal sources of mesenchymal stem cells: Wharton&#x2019;s jelly, amnion and chorion. Cell Mol Biol Lett. 2011;16(3):493&#x2013;514. doi: 10.2478/s11658-011-0019-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/s11658-011-0019-7</ArticleId><ArticleId IdType="pmc">PMC6275796</ArticleId><ArticleId IdType="pubmed">21786036</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Pardo VM, Vernot JP. Mesenchymal stem cells promote a primitive phenotype CD34+c-kit+ in human cord blood-derived hematopoietic stem cells during ex vivo expansion. Cell Mol Biol Lett. 2013;18(1):11&#x2013;33. doi: 10.2478/s11658-012-0036-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/s11658-012-0036-1</ArticleId><ArticleId IdType="pmc">PMC6275752</ArticleId><ArticleId IdType="pubmed">23104253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahani-Nahayati M, Shariati A, Mahmoodi M, Olegovna Zekiy A, Javidi K, Shamlou S, Mousakhani A, Zamani M, Hassanzadeh A. Stem cell in neurodegenerative disorders; an emerging strategy. Int J Develop Neurosci. 2021;78:5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33650716</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin R, Li M, Luo M, Teng T, Pan Y, Huang H. Correction to: Mesenchymal stem cells decrease blood&#x2013;brain barrier permeability in rats with severe acute pancreatitis. Cell Mol Biol Lett. 2019;24(1):56. doi: 10.1186/s11658-019-0176-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-019-0176-7</ArticleId><ArticleId IdType="pmc">PMC6710877</ArticleId><ArticleId IdType="pubmed">31462899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Oh K-W, Jin HK, Bae J-S. Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases. BMB Rep. 2018;51(11):545. doi: 10.5483/BMBRep.2018.51.11.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2018.51.11.255</ArticleId><ArticleId IdType="pmc">PMC6283021</ArticleId><ArticleId IdType="pubmed">30463642</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Furno D, Mannino G, Giuffrida R. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases. J Cell Physiol. 2018;233(5):3982&#x2013;3999. doi: 10.1002/jcp.26192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26192</ArticleId><ArticleId IdType="pubmed">28926091</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Yu P, Wang W, Zhang P, Yang H, Li S, Zhang L. Gene expression profiles of various cytokines in mesenchymal stem cells derived from umbilical cord tissue and bone marrow following infection with human cytomegalovirus. Cell Mol Biol Lett. 2014;19(1):140&#x2013;157. doi: 10.2478/s11658-014-0187-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/s11658-014-0187-3</ArticleId><ArticleId IdType="pmc">PMC6275684</ArticleId><ArticleId IdType="pubmed">24569981</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorabi AM, Kiaie N, Barreto GE, Read MI, Tafti HA, Sahebkar A. The therapeutic potential of mesenchymal stem cell&#x2013;derived exosomes in treatment of neurodegenerative diseases. Mol Neurobiol. 2019;56(12):8157&#x2013;8167. doi: 10.1007/s12035-019-01663-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01663-0</ArticleId><ArticleId IdType="pubmed">31197655</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatullo M, Codispoti B, Spagnuolo G, Zavan B. Human periapical cyst-derived stem cells can be a smart &#x201c;lab-on-a-cell&#x201d; to investigate neurodegenerative diseases and the related alteration of the exosomes&#x2019; content. Brain Sci. 2019;9(12):358. doi: 10.3390/brainsci9120358.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci9120358</ArticleId><ArticleId IdType="pmc">PMC6955839</ArticleId><ArticleId IdType="pubmed">31817546</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Huang H, Hu W, Li X. Mesenchymal stem cell-derived exosomes for the treatment of neurodegenerative diseases: existing problems and prospects in application. Chin J Tissue Eng Res. 2019;23(9):1441.</Citation></Reference><Reference><Citation>Wang X, Zhou Y, Gao Q, Ping D, Wang Y, Wu W, Lin X, Fang Y, Zhang J, Shao A. The role of exosomal microRNAs and oxidative stress in neurodegenerative diseases. Oxid Med Cell Longevity. 2020;2020:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641266</ArticleId><ArticleId IdType="pubmed">33193999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei H, Xu Y, Chen Q, Chen H, Zhu X, Li Y. Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis. Cell Death Dis. 2020;11(4):290. doi: 10.1038/s41419-020-2490-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2490-4</ArticleId><ArticleId IdType="pmc">PMC7184756</ArticleId><ArticleId IdType="pubmed">32341353</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyanaga T, Ueda Y, Miyanaga A, Yagishita M, Hama N. Angiogenesis after administration of basic fibroblast growth factor induces proliferation and differentiation of mesenchymal stem cells in elastic perichondrium in an in vivo model: mini review of three sequential republication-abridged reports. Cell Mol Biol Lett. 2018;23(1):49. doi: 10.1186/s11658-018-0113-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-018-0113-1</ArticleId><ArticleId IdType="pmc">PMC6173837</ArticleId><ArticleId IdType="pubmed">30323846</ArticleId></ArticleIdList></Reference><Reference><Citation>Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2(10):734&#x2013;744. doi: 10.1038/35094583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35094583</ArticleId><ArticleId IdType="pubmed">11584311</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan L, Mao C, Xu Y, Shi C, Hu X, Zhang S, Yang Z, Hu Z, Sun H, Fan Y. New insights into the pathogenesis of Alzheimer&#x2019;s disease. Front Neurol. 2019;10:1312. doi: 10.3389/fneur.2019.01312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01312</ArticleId><ArticleId IdType="pmc">PMC6965067</ArticleId><ArticleId IdType="pubmed">31998208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280(7):5892&#x2013;5901. doi: 10.1074/jbc.M404751200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M404751200</ArticleId><ArticleId IdType="pubmed">15590663</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola KL, Klein WL. Amyloid &#x3b2; oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. Acta Neuropathol. 2015;129(2):183&#x2013;206. doi: 10.1007/s00401-015-1386-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1386-3</ArticleId><ArticleId IdType="pmc">PMC4390393</ArticleId><ArticleId IdType="pubmed">25604547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisht K, Sharma K, Tremblay M. Chronic stress as a risk factor for Alzheimer's disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. Neurobiol Stress. 2018;9:9&#x2013;21. doi: 10.1016/j.ynstr.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ynstr.2018.05.003</ArticleId><ArticleId IdType="pmc">PMC6035903</ArticleId><ArticleId IdType="pubmed">29992181</ArticleId></ArticleIdList></Reference><Reference><Citation>Poston KL, Ua Cruadhlaoich MA, Santoso LF, Bernstein JD, Liu T, Wang Y, Rutt B, Kerchner GA, Zeineh MM. Substantia nigra volume dissociates bradykinesia and rigidity from tremor in Parkinson&#x2019;s Disease: a 7 Tesla imaging study. J Parkinsons Dis. 2020;10(2):591&#x2013;604. doi: 10.3233/JPD-191890.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-191890</ArticleId><ArticleId IdType="pmc">PMC7242837</ArticleId><ArticleId IdType="pubmed">32250317</ArticleId></ArticleIdList></Reference><Reference><Citation>Klockgether T. Parkinson&#x2019;s disease: clinical aspects. Cell Tissue Res. 2004;318(1):115&#x2013;120. doi: 10.1007/s00441-004-0975-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-004-0975-6</ArticleId><ArticleId IdType="pubmed">15365814</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman JM, Jager PLD, Feany MB. Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol. 2011;6(1):193&#x2013;222. doi: 10.1146/annurev-pathol-011110-130242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-011110-130242</ArticleId><ArticleId IdType="pubmed">21034221</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty KM, Silveira-Moriyama L, Parkkinen L, Healy DG, Farrell M, Mencacci NE, Ahmed Z, Brett FM, Hardy J, Quinn N, et al. Parkin disease: a clinicopathologic entity? JAMA Neurol. 2013;70(5):571&#x2013;579. doi: 10.1001/jamaneurol.2013.172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.172</ArticleId><ArticleId IdType="pmc">PMC4202385</ArticleId><ArticleId IdType="pubmed">23459986</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudic S, Maison P, Dolbeau G, Boiss&#xe9; M-F, Bartolomeo P, Dalla Barba G, Traykov L, Bachoud-L&#xe9;vi A-C. Cognitive impairment related to apathy in early Huntington&#x2019;s disease. Dement Geriatr Cogn Disord. 2006;21(5&#x2013;6):316&#x2013;321. doi: 10.1159/000091523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000091523</ArticleId><ArticleId IdType="pubmed">16484810</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrasate M, Finkbeiner S. Protein aggregates in Huntington's disease. Exp Neurol. 2012;238(1):1&#x2013;11. doi: 10.1016/j.expneurol.2011.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.12.013</ArticleId><ArticleId IdType="pmc">PMC3909772</ArticleId><ArticleId IdType="pubmed">22200539</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WJ, Chen WW, Zhang X. Huntington's disease: molecular basis of pathology and status of current therapeutic approaches. Exp Ther Med. 2016;12(4):1951&#x2013;1956. doi: 10.3892/etm.2016.3566.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3566</ArticleId><ArticleId IdType="pmc">PMC5038571</ArticleId><ArticleId IdType="pubmed">27698679</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L, Bilgutay A, Zhang Y-J, Vanderwyde T, Citro A, Mehta T, Zaarur N, McKee A, Bowser R, Sherman M. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5(10):e13250. doi: 10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang MY, Markmiller S, Vu AQ, Javaherian A, Dowdle WE, Jolivet P, Bushway PJ, Castello NA, Baral A, Chan MY, et al. Small-molecule modulation of TDP-43 recruitment to stress granules prevents persistent TDP-43 accumulation in ALS/FTD. Neuron. 2019;103(5):802&#x2013;19.e11. doi: 10.1016/j.neuron.2019.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.048</ArticleId><ArticleId IdType="pmc">PMC6728177</ArticleId><ArticleId IdType="pubmed">31272829</ArticleId></ArticleIdList></Reference><Reference><Citation>Miltenberger-Miltenyi G, Concei&#xe7;&#xe3;o VA, Gromicho M, Pronto-Laborinho AC, Pinto S, Andersen PM, de Carvalho M. C9orf72 expansion is associated with accelerated decline of respiratory function and decreased survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(1):118&#x2013;120. doi: 10.1136/jnnp-2018-318032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318032</ArticleId><ArticleId IdType="pubmed">29661924</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SS, Yoo SW, Park TS, Ahn SC, Jeong HS, Kim JW, Chang DY, Cho KG, Kim SU, Huh Y, et al. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells. 2008;26(9):2217&#x2013;2228. doi: 10.1634/stemcells.2008-0108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/stemcells.2008-0108</ArticleId><ArticleId IdType="pubmed">18617687</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Xie Z, Wei L, Yang H, Yang S, Zhu Z, Wang P, Zhao C, Bi J. Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an A&#x3b2;PP/PS1 transgenic mouse model. Stem Cell Res Ther. 2013;4(4):76. doi: 10.1186/scrt227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/scrt227</ArticleId><ArticleId IdType="pmc">PMC3854736</ArticleId><ArticleId IdType="pubmed">23826983</ArticleId></ArticleIdList></Reference><Reference><Citation>Harasymiak-Krzy&#x17c;anowska I, Niedojad&#x142;o A, Karwat J, Kotu&#x142;a L, Gil-Kulik P, Sawiuk M, Kocki J. Adipose tissue-derived stem cells show considerable promise for regenerative medicine applications. Cell Mol Biol Lett. 2013;18(4):479&#x2013;493. doi: 10.2478/s11658-013-0101-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/s11658-013-0101-4</ArticleId><ArticleId IdType="pmc">PMC6275722</ArticleId><ArticleId IdType="pubmed">23949841</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W, Feng Z, Xu J, Jiang Z, Feng M. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats. Brain Res. 2019;1710:61&#x2013;73. doi: 10.1016/j.brainres.2018.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.034</ArticleId><ArticleId IdType="pubmed">30586546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff EF, Mutlu L, Massasa EE, Elsworth JD, Eugene Redmond D, Jr., Taylor HS. Endometrial stem cell transplantation in MPTP-exposed primates: an alternative cell source for treatment of Parkinson's disease. J Cell Mol Med. 2015;19(1):249&#x2013;256. doi: 10.1111/jcmm.12433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12433</ArticleId><ArticleId IdType="pmc">PMC4288367</ArticleId><ArticleId IdType="pubmed">25283241</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Fu W, Zhuang W, Lv C, Li F, Wang X. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease. J Neurosci Res. 2017;95(3):907&#x2013;917. doi: 10.1002/jnr.23879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23879</ArticleId><ArticleId IdType="pubmed">27617772</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkman R, Offen D. Concise review: mesenchymal stem cells in neurodegenerative diseases. Stem Cells. 2017;35(8):1867&#x2013;1880. doi: 10.1002/stem.2651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2651</ArticleId><ArticleId IdType="pubmed">28589621</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med. 2010;5(6):933&#x2013;946. doi: 10.2217/rme.10.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/rme.10.72</ArticleId><ArticleId IdType="pmc">PMC3017479</ArticleId><ArticleId IdType="pubmed">21082892</ArticleId></ArticleIdList></Reference><Reference><Citation>Schain M, Kreisl WC. Neuroinflammation in neurodegenerative disorders-a review. Curr Neurol Neurosci Rep. 2017;17(3):25. doi: 10.1007/s11910-017-0733-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-017-0733-2</ArticleId><ArticleId IdType="pubmed">28283959</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (review) Mol Med Rep. 2016;13(4):3391&#x2013;3396. doi: 10.3892/mmr.2016.4948.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.4948</ArticleId><ArticleId IdType="pmc">PMC4805095</ArticleId><ArticleId IdType="pubmed">26935478</ArticleId></ArticleIdList></Reference><Reference><Citation>Subhramanyam CS, Wang C, Hu Q, Dheen ST. Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol. 2019;94:112&#x2013;120. doi: 10.1016/j.semcdb.2019.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.004</ArticleId><ArticleId IdType="pubmed">31077796</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhang R, Yan K, Chen F, Huang W, Lv B, Sun C, Xu L, Li F, Jiang X. Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6. J Neuroinflammation. 2014;11:135. doi: 10.1186/1742-2094-11-135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-135</ArticleId><ArticleId IdType="pmc">PMC4128538</ArticleId><ArticleId IdType="pubmed">25088370</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zeng R, Wang Y, Huang W, Hu B, Zhu G, Zhang R, Li F, Han J, Li Y. Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6. Brain Res. 2019;1724:146422. doi: 10.1016/j.brainres.2019.146422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2019.146422</ArticleId><ArticleId IdType="pubmed">31472111</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M, Cao Y, Guo X, Chu X, Li T, Xue H, Xin D, Yuan L, Ke H, Li G, et al. Mesenchymal stem cell-derived extracellular vesicles promote microglial M2 polarization after subarachnoid hemorrhage in rats and involve the AMPK/NF-&#x3ba;B signaling pathway. Biomed Pharmacother. 2021;133:111048. doi: 10.1016/j.biopha.2020.111048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.111048</ArticleId><ArticleId IdType="pubmed">33378955</ArticleId></ArticleIdList></Reference><Reference><Citation>Na L, Wang S, Liu T, Zhang L. Ultrashort wave combined with human umbilical cord mesenchymal stem cell (HUC-MSC) transplantation inhibits NLRP3 inflammasome and improves spinal cord injury via MK2/TTP signalling pathway. Biomed Res Int. 2020;2020:3021750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7738785</ArticleId><ArticleId IdType="pubmed">33376718</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Zhang M, Liu H, Zhu R, He H, Zhou Y, Zhang Y, Li C, Liang D, Zeng Q, et al. Bone marrow mesenchymal stem cell-derived exosomes attenuate cerebral ischemia&#x2013;reperfusion injury-induced neuroinflammation and pyroptosis by modulating microglia M1/M2 phenotypes. Exp Neurol. 2021;341:113700. doi: 10.1016/j.expneurol.2021.113700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2021.113700</ArticleId><ArticleId IdType="pubmed">33741350</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui GH, Guo HD, Li H, Zhai Y, Gong ZB, Wu J, Liu JS, Dong YR, Hou SX, Liu JR. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease. Immun Ageing. 2019;16:10. doi: 10.1186/s12979-019-0150-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-019-0150-2</ArticleId><ArticleId IdType="pmc">PMC6515654</ArticleId><ArticleId IdType="pubmed">31114624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kook MG, Lee S, Shin N, Kong D, Kim DH, Kim MS, Kang HK, Choi SW, Kang KS. Repeated intramuscular transplantations of hUCB-MSCs improves motor function and survival in the SOD1 G(93)A mice through activation of AMPK. Sci Rep. 2020;10(1):1572. doi: 10.1038/s41598-020-58221-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-58221-1</ArticleId><ArticleId IdType="pmc">PMC6994691</ArticleId><ArticleId IdType="pubmed">32005848</ArticleId></ArticleIdList></Reference><Reference><Citation>Sironi F, Vallarola A, Violatto MB, Talamini L, Freschi M, De Gioia R, Capelli C, Agostini A, Moscatelli D, Tortarolo M, et al. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice. Stem Cell Res. 2017;25:166&#x2013;178. doi: 10.1016/j.scr.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2017.11.005</ArticleId><ArticleId IdType="pubmed">29154076</ArticleId></ArticleIdList></Reference><Reference><Citation>Skok M. Mesenchymal stem cells as a potential therapeutic tool to cure cognitive impairment caused by neuroinflammation. World J Stem Cells. 2021;13(8):1072&#x2013;1083. doi: 10.4252/wjsc.v13.i8.1072.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v13.i8.1072</ArticleId><ArticleId IdType="pmc">PMC8422935</ArticleId><ArticleId IdType="pubmed">34567426</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Y, Cao N, Zhai J, Zeng Q, Zheng P, Su R, Liao T, Liu J, Pei H, Fan Z, et al. HGF mediates clinical-grade human umbilical cord-derived mesenchymal stem cells improved functional recovery in a senescence-accelerated mouse model of Alzheimer's disease. Adv Sci. 2020;7(17):1903809. doi: 10.1002/advs.201903809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.201903809</ArticleId><ArticleId IdType="pmc">PMC7507104</ArticleId><ArticleId IdType="pubmed">32995116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Lee D, Chang EH, Kim JH, Hwang JW, Kim JY, Kyung JW, Kim SH, Oh JS, Shim SM, et al. GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer's disease model. Stem Cells Dev. 2015;24(20):2378&#x2013;2390. doi: 10.1089/scd.2014.0487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2014.0487</ArticleId><ArticleId IdType="pmc">PMC4598918</ArticleId><ArticleId IdType="pubmed">26154268</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H, Chang KA. Therapeutic potential of repeated intravenous transplantation of human adipose-derived stem cells in subchronic MPTP-induced Parkinson's disease mouse model. Int J Mol Sci. 2020;21:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7663651</ArticleId><ArticleId IdType="pubmed">33143234</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalali MS, Sarkaki A, Farbood Y, Azandeh SS, Mansouri E, Ghasemi Dehcheshmeh M, Saki G. Transplanted Wharton's jelly mesenchymal stem cells improve memory and brain hippocampal electrophysiology in rat model of Parkinson's disease. J Chem Neuroanat. 2020;110:101865. doi: 10.1016/j.jchemneu.2020.101865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2020.101865</ArticleId><ArticleId IdType="pubmed">32991967</ArticleId></ArticleIdList></Reference><Reference><Citation>Park BN, Kim JH, Lee K, Park SH, An YS. Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT. Eur Radiol. 2015;25(5):1487&#x2013;1496. doi: 10.1007/s00330-014-3549-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-014-3549-3</ArticleId><ArticleId IdType="pubmed">25504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi MJ, Aliaghaei A, Boroujeni ME, Khodagholi F, Meftahi G, Abdollahifar MA, Ahmadi H, Danyali S, Daftari M, Sadeghi Y. Human umbilical cord matrix stem cells reverse oxidative stress-induced cell death and ameliorate motor function and striatal atrophy in rat model of Huntington disease. Neurotox Res. 2018;34(2):273&#x2013;284. doi: 10.1007/s12640-018-9884-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-018-9884-4</ArticleId><ArticleId IdType="pubmed">29520722</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Wu J, Lang L, Hu J, Tang H, Xu J, Sun B. Implantation of glial cell line-derived neurotrophic factor-expressing adipose tissue-derived stromal cells in a rat Parkinson's disease model. Neurol Res. 2020;42(8):712&#x2013;720. doi: 10.1080/01616412.2020.1783473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2020.1783473</ArticleId><ArticleId IdType="pubmed">32567526</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia KO, Ornellas FLM, Martin PKM, Patti CL, Mello LE, Frussa-Filho R, Han SW, Longo BM. Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer's disease. Front Aging Neurosci. 2014;6:30. doi: 10.3389/fnagi.2014.00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00030</ArticleId><ArticleId IdType="pmc">PMC3945612</ArticleId><ArticleId IdType="pubmed">24639647</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Zhao G, Kang X, Su L. Effects of lateral ventricular transplantation of bone marrow-derived mesenchymal stem cells modified with brain-derived neurotrophic factor gene on cognition in a rat model of Alzheimer's disease. Neural Regen Res. 2012;7(4):245&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4353094</ArticleId><ArticleId IdType="pubmed">25806063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Wang J, Wang S, Zou C, Li X, Guan Y, Chen Z, Zhang YA. Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys. Sci Rep. 2013;3:2786. doi: 10.1038/srep02786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep02786</ArticleId><ArticleId IdType="pmc">PMC4070584</ArticleId><ArticleId IdType="pubmed">24071770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, et al. Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington's disease mouse models. Mol Ther. 2016;24(5):965&#x2013;977. doi: 10.1038/mt.2016.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2016.12</ArticleId><ArticleId IdType="pmc">PMC4881765</ArticleId><ArticleId IdType="pubmed">26765769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Hu W, Feng Z, Feng M. BDNF-overexpressing human umbilical cord mesenchymal stem cell-derived motor neurons improve motor function and prolong survival in amyotrophic lateral sclerosis mice. Neurol Res. 2021;43(3):199&#x2013;209. doi: 10.1080/01616412.2020.1834775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2020.1834775</ArticleId><ArticleId IdType="pubmed">33076784</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai K, Jin G, Navaratna D, Lo EH. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J. 2009;276(17):4644&#x2013;4652. doi: 10.1111/j.1742-4658.2009.07176.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2009.07176.x</ArticleId><ArticleId IdType="pmc">PMC3712842</ArticleId><ArticleId IdType="pubmed">19664070</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy R, Offen D. Promising opportunities for treating neurodegenerative diseases with mesenchymal stem cell-derived exosomes. Biomolecules. 2020;10(9):1320. doi: 10.3390/biom10091320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10091320</ArticleId><ArticleId IdType="pmc">PMC7564210</ArticleId><ArticleId IdType="pubmed">32942544</ArticleId></ArticleIdList></Reference><Reference><Citation>Teli P, Kale V, Vaidya A. Extracellular vesicles isolated from mesenchymal stromal cells primed with neurotrophic factors and signaling modifiers as potential therapeutics for neurodegenerative diseases. Curr Res Transl Med. 2021;69(2):103286. doi: 10.1016/j.retram.2021.103286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.retram.2021.103286</ArticleId><ArticleId IdType="pubmed">33826976</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh MY, Lim SM, Oh K-W, Cho K-A, Park J, Kim K-S, Lee S-J, Kwon M-S, Kim SH. Mesenchymal stem cells modulate the functional properties of microglia via TGF-&#x3b2; secretion. Stem Cells Transl Med. 2016;5(11):1538&#x2013;1549. doi: 10.5966/sctm.2015-0217.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2015-0217</ArticleId><ArticleId IdType="pmc">PMC5070497</ArticleId><ArticleId IdType="pubmed">27400795</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyurkchiev D, Bochev I, Ivanova-Todorova E, Mourdjeva M, Oreshkova T, Belemezova K, Kyurkchiev S. Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells. 2014;6(5):552&#x2013;570. doi: 10.4252/wjsc.v6.i5.552.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v6.i5.552</ArticleId><ArticleId IdType="pmc">PMC4178255</ArticleId><ArticleId IdType="pubmed">25426252</ArticleId></ArticleIdList></Reference><Reference><Citation>Porro C, Cianciulli A, Panaro MA. The regulatory role of IL-10 in neurodegenerative diseases. Biomolecules. 2020;10(7):1017. doi: 10.3390/biom10071017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10071017</ArticleId><ArticleId IdType="pmc">PMC7407888</ArticleId><ArticleId IdType="pubmed">32659950</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadan O, Melamed E, Offen D. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Expert Opin Biol Ther. 2009;9(12):1487&#x2013;1497. doi: 10.1517/14712590903321439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712590903321439</ArticleId><ArticleId IdType="pubmed">19821796</ArticleId></ArticleIdList></Reference><Reference><Citation>Croitoru-Lamoury J, Lamoury FM, Zaunders JJ, Veas LA, Brew BJ. Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-&#x3b2;, and copaxone. J Interferon Cytokine Res. 2007;27(1):53&#x2013;64. doi: 10.1089/jir.2006.0037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2006.0037</ArticleId><ArticleId IdType="pubmed">17266444</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Hale JS, Rich JN, Ransohoff RM, Lathia JD. Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends Neurosci. 2012;35(10):619&#x2013;628. doi: 10.1016/j.tins.2012.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2012.06.003</ArticleId><ArticleId IdType="pmc">PMC3461091</ArticleId><ArticleId IdType="pubmed">22784557</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2):141&#x2013;150. doi: 10.1016/j.stem.2007.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2007.11.014</ArticleId><ArticleId IdType="pubmed">18371435</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding C, Heuser J, Stahl P. Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol. 1984;35(2):256&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">6151502</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan B-T, Teng K, Wu C, Adam M, Johnstone RM. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol. 1985;101(3):942&#x2013;948. doi: 10.1083/jcb.101.3.942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.101.3.942</ArticleId><ArticleId IdType="pmc">PMC2113705</ArticleId><ArticleId IdType="pubmed">2993317</ArticleId></ArticleIdList></Reference><Reference><Citation>Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851&#x2013;858. doi: 10.1002/stem.2575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2575</ArticleId><ArticleId IdType="pubmed">28294454</ArticleId></ArticleIdList></Reference><Reference><Citation>Razeghian E, Margiana R, Chupradit S, Bokov DO, Abdelbasset WK, Marofi F, Shariatzadeh S, Tosan F, Jarahian M. Mesenchymal stem/stromal cells as a vehicle for cytokine delivery: an emerging approach for tumor immunotherapy. Front Med. 2021;8:721174. doi: 10.3389/fmed.2021.721174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.721174</ArticleId><ArticleId IdType="pmc">PMC8430327</ArticleId><ArticleId IdType="pubmed">34513882</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahbaran M, Baghini SS, Mardasi M, Razeghian E. MSCs modifies the proliferation of leukemia MOLT-4 cells and induces their apoptosis through up-regulating Bax, caspase-3, and-8, and down-regulating Bcl-2 expression. Ann Cancer Res Ther. 2021;29(1):79&#x2013;84. doi: 10.4993/acrt.29.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.4993/acrt.29.79</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS, Beheshtkhoo N, Kouhbanani MAJ, Marofi F, Nikoo M. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther. 2021;12(1):1&#x2013;22. doi: 10.1186/s13287-021-02378-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-021-02378-7</ArticleId><ArticleId IdType="pmc">PMC8138094</ArticleId><ArticleId IdType="pubmed">34020704</ArticleId></ArticleIdList></Reference><Reference><Citation>Marote A, Teixeira FG, Mendes-Pinheiro B, Salgado AJ. MSCs-derived exosomes: cell-secreted nanovesicles with regenerative potential. Front Pharmacol. 2016;7:231. doi: 10.3389/fphar.2016.00231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2016.00231</ArticleId><ArticleId IdType="pmc">PMC4971062</ArticleId><ArticleId IdType="pubmed">27536241</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghadasi S, Elveny M, Rahman HS, Suksatan W, Jalil AT, Abdelbasset WK, Yumashev AV, Shariatzadeh S, Motavalli R, Behzad F, et al. A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine. J Transl Med. 2021;19(1):302. doi: 10.1186/s12967-021-02980-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02980-6</ArticleId><ArticleId IdType="pmc">PMC8273572</ArticleId><ArticleId IdType="pubmed">34253242</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadli AS, Ballasy N, Edalat P, Patel VB. Inside (sight) of tiny communicator: exosome biogenesis, secretion, and uptake. Mol Cell Biochem. 2020;467(1):77&#x2013;94. doi: 10.1007/s11010-020-03703-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-020-03703-z</ArticleId><ArticleId IdType="pubmed">32088833</ArticleId></ArticleIdList></Reference><Reference><Citation>Losurdo M, Pedrazzoli M, D'Agostino C, Elia CA, Massenzio F, Lonati E, Mauri M, Rizzi L, Molteni L, Bresciani E, et al. Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease. Stem Cells Transl Med. 2020;9(9):1068&#x2013;1084. doi: 10.1002/sctm.19-0327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.19-0327</ArticleId><ArticleId IdType="pmc">PMC7445021</ArticleId><ArticleId IdType="pubmed">32496649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H-X, Liang F-C, Gu P, Xu B-L, Xu H-J, Wang W-T, Hou J-Y, Xie D-X, Chai X-Q, An S-J. Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy. Cell Death Dis. 2020;11(4):288. doi: 10.1038/s41419-020-2473-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2473-5</ArticleId><ArticleId IdType="pmc">PMC7184757</ArticleId><ArticleId IdType="pubmed">32341347</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes-Pinheiro B, Anjo SI, Manadas B, Da Silva JD, Marote A, Behie LA, Teixeira FG, Salgado AJ. Bone marrow mesenchymal stem cells' secretome exerts neuroprotective effects in a Parkinson's disease rat model. Front Bioeng Biotechnol. 2019;7:294. doi: 10.3389/fbioe.2019.00294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2019.00294</ArticleId><ArticleId IdType="pmc">PMC6838134</ArticleId><ArticleId IdType="pubmed">31737616</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C, Li X, Ba L, Zhang M, Yang Y, Gao Y, Sun Z, Han Q, Zhao RC. MSC-derived exosomes can enhance the angiogenesis of human brain MECs and show therapeutic potential in a mouse model of Parkinson's disease. Aging Dis. 2021;12(5):1211&#x2013;1222. doi: 10.14336/AD.2020.1221.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.1221</ArticleId><ArticleId IdType="pmc">PMC8279521</ArticleId><ArticleId IdType="pubmed">34341703</ArticleId></ArticleIdList></Reference><Reference><Citation>Farahzadi R, Fathi E, Vietor I. Mesenchymal Stem cells could be considered as a candidate for further studies in cell-based therapy of Alzheimer's disease via targeting the signaling pathways. ACS Chem Neurosci. 2020;11(10):1424&#x2013;1435. doi: 10.1021/acschemneuro.0c00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00052</ArticleId><ArticleId IdType="pubmed">32310632</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Y, Cao N, Zhai J, Zeng Q, Zheng P, Su R, Liao T, Liu J, Pei H, Fan Z, et al. HGF mediates clinical-grade human umbilical cord-derived mesenchymal stem cells improved functional recovery in a senescence-accelerated mouse model of Alzheimer's disease. Adv Sci (Weinh) 2020;7(17):1903809. doi: 10.1002/advs.201903809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.201903809</ArticleId><ArticleId IdType="pmc">PMC7507104</ArticleId><ArticleId IdType="pubmed">32995116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Ma S, Zhang C, Cao W, Liu M, Li D, Lv P, Xing Q, Qu R, Yao N, et al. Human umbilical cord mesenchymal stem cells transplantation improves cognitive function in Alzheimer's disease mice by decreasing oxidative stress and promoting hippocampal neurogenesis. Behav Brain Res. 2017;320:291&#x2013;301. doi: 10.1016/j.bbr.2016.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2016.12.021</ArticleId><ArticleId IdType="pubmed">28007537</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Liu X, Chen H, Cao J, Zhang L, Hu X, Wang J. Role of SIRT1 and AMPK in mesenchymal stem cells differentiation. Ageing Res Rev. 2014;13:55&#x2013;64. doi: 10.1016/j.arr.2013.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2013.12.002</ArticleId><ArticleId IdType="pubmed">24333965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng XY, Wan QQ, Zheng CY, Zhou HL, Dong XY, Deng QS, Yao H, Fu Q, Gao M, Yan ZJ, et al. Amniotic mesenchymal stem cells decrease A&#x3b2; deposition and improve memory in APP/PS1 transgenic mice. Neurochem Res. 2017;42(8):2191&#x2013;2207. doi: 10.1007/s11064-017-2226-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2226-8</ArticleId><ArticleId IdType="pubmed">28397068</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Ma S, Yang B, Huang T, Meng N, Xu L, Xing Q, Zhang Y, Zhang K, Li Q, et al. Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer's disease. Behav Brain Res. 2018;339:297&#x2013;304. doi: 10.1016/j.bbr.2017.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2017.10.032</ArticleId><ArticleId IdType="pmc">PMC5729114</ArticleId><ArticleId IdType="pubmed">29102593</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasiri E, Alizadeh A, Roushandeh AM, Gazor R, Hashemi-Firouzi N, Golipoor Z. Melatonin-pretreated adipose-derived mesenchymal stem cells efficiently improved learning, memory, and cognition in an animal model of Alzheimer's disease. Metab Brain Dis. 2019;34(4):1131&#x2013;1143. doi: 10.1007/s11011-019-00421-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-019-00421-4</ArticleId><ArticleId IdType="pubmed">31129766</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramezani M, Komaki A, Hashemi-Firouzi N, Mortezaee K, Faraji N, Golipoor Z. Therapeutic effects of melatonin-treated bone marrow mesenchymal stem cells (BMSC) in a rat model of Alzheimer's disease. J Chem Neuroanat. 2020;108:101804. doi: 10.1016/j.jchemneu.2020.101804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2020.101804</ArticleId><ArticleId IdType="pubmed">32470495</ArticleId></ArticleIdList></Reference><Reference><Citation>Giunti D, Marini C, Parodi B, Usai C, Milanese M, Bonanno G, KerleroRosbo N, Uccelli A. Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation. Sci Rep. 2021;11(1):1740. doi: 10.1038/s41598-021-81039-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81039-4</ArticleId><ArticleId IdType="pmc">PMC7814007</ArticleId><ArticleId IdType="pubmed">33462263</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano M, Kubota K, Kobayashi E, Chikenji TS, Saito Y, Konari N, Fujimiya M. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer's disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020;10(1):10772. doi: 10.1038/s41598-020-67460-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67460-1</ArticleId><ArticleId IdType="pmc">PMC7330036</ArticleId><ArticleId IdType="pubmed">32612165</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K, Zhang R, Lu Y, Wen L, Li Y, Duan R, Yao Y, Jia Y. Lin28B regulates the fate of grafted mesenchymal stem cells and enhances their protective effects against Alzheimer's disease by upregulating IGF-2. J Cell Physiol. 2019;234(12):21860&#x2013;21876. doi: 10.1002/jcp.28750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28750</ArticleId><ArticleId IdType="pubmed">31066045</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A, Zhao J, Fan C, Zhu L, Huang C, Li Q, Gan D, Wen C, Chen M, Lu D. Delivery of exogenous proteins by mesenchymal stem cells attenuates early memory deficits in a murine model of Alzheimer's disease. Neurobiol Aging. 2020;86:81&#x2013;91. doi: 10.1016/j.neurobiolaging.2019.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.10.012</ArticleId><ArticleId IdType="pubmed">31837910</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff EF, Gao XB, Yao KV, Andrews ZB, Du H, Elsworth JD, Taylor HS. Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model. J Cell Mol Med. 2011;15(4):747&#x2013;755. doi: 10.1111/j.1582-4934.2010.01068.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2010.01068.x</ArticleId><ArticleId IdType="pmc">PMC2998585</ArticleId><ArticleId IdType="pubmed">20406327</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate CC, Chou VP, Campos C, Moalem AS, Di Monte DA, McGrogan M, Case CC, Manning-Bog AB. Mesenchymal stromal SB623 cell implantation mitigates nigrostriatal dopaminergic damage in a mouse model of Parkinson's disease. J Tissue Eng Regen Med. 2017;11(6):1835&#x2013;1843. doi: 10.1002/term.2081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/term.2081</ArticleId><ArticleId IdType="pubmed">26440859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao YX, He BP, Tay SS. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. J Neuroimmunol. 2009;216(1&#x2013;2):39&#x2013;50. doi: 10.1016/j.jneuroim.2009.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.09.003</ArticleId><ArticleId IdType="pubmed">19819031</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SH, Kim HN, Park HJ, Shin JY, Kim DY, Lee PH. The cleavage effect of mesenchymal stem cell and its derived matrix metalloproteinase-2 on extracellular &#x3b1;-synuclein aggregates in Parkinsonian models. Stem Cells Transl Med. 2017;6(3):949&#x2013;961. doi: 10.5966/sctm.2016-0111.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2016-0111</ArticleId><ArticleId IdType="pmc">PMC5442774</ArticleId><ArticleId IdType="pubmed">28297586</ArticleId></ArticleIdList></Reference><Reference><Citation>Du C, Jiang M, Wei X, Qin J, Xu H, Wang Y, Zhang Y, Zhou D, Xue H, Zheng S, et al. Transplantation of human matrix metalloproteinase-1 gene-modified bone marrow-derived mesenchymal stem cell attenuates CCL4-induced liver fibrosis in rats. Int J Mol Med. 2018;41(6):3175&#x2013;3184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881841</ArticleId><ArticleId IdType="pubmed">29512750</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisati F, Bossolasco P, Meregalli M, Cova L, Belicchi M, Gavina M, Marchesi C, Calzarossa C, Soligo D, Lambertenghi-Deliliers G, et al. Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases. Cell Transplant. 2007;16(1):41&#x2013;55. doi: 10.3727/000000007783464443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/000000007783464443</ArticleId><ArticleId IdType="pubmed">17436854</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri-Mohammadi S, Alani B, Karimian M, Moradian-Tehrani R, Noureddini M. Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy. Mol Biol Rep. 2019;46(4):4293&#x2013;4302. doi: 10.1007/s11033-019-04883-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-019-04883-8</ArticleId><ArticleId IdType="pubmed">31123907</ArticleId></ArticleIdList></Reference><Reference><Citation>CalicedaSilva C, Azevedo BN, Machado DC, Zimmer ER, Martins LAM, da Costa JC. Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson's disease. Behav Brain Res. 2017;324:30&#x2013;40. doi: 10.1016/j.bbr.2017.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2017.02.005</ArticleId><ArticleId IdType="pubmed">28167338</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerri S, Greco R, Levandis G, Ghezzi C, Mangione AS, Fuzzati-Armentero M-T, Bonizzi A, Avanzini MA, Maccario R, Blandini F. Intracarotid infusion of mesenchymal stem cells in an animal model of parkinson's disease, focusing on cell distribution and neuroprotective and behavioral effects. Stem Cells Transl Med. 2015;4(9):1073&#x2013;1085. doi: 10.5966/sctm.2015-0023.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2015-0023</ArticleId><ArticleId IdType="pmc">PMC4542871</ArticleId><ArticleId IdType="pubmed">26198165</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoban DB, Howard L, Dowd E. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease. Neuroscience. 2015;303:402&#x2013;411. doi: 10.1016/j.neuroscience.2015.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.07.014</ArticleId><ArticleId IdType="pubmed">26166730</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Zhang Q, Li M, Gao P, Huang K, Beejadhursing R, Jiang W, Lei T, Zhu M, Shu K. GDNF promotes survival and therapeutic efficacy of human adipose-derived mesenchymal stem cells in a mouse model of Parkinson's disease. Cell Transplant. 2020;29:963689720908512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444207</ArticleId><ArticleId IdType="pubmed">32292068</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhuang W, Fu W, Wang X, Lv E, Li F, Zhou S, Rausch W-D, Wang X. The lentiviral-mediated Nurr1 genetic engineering mesenchymal stem cells protect dopaminergic neurons in a rat model of Parkinson's disease. Am J Transl Res. 2018;10(6):1583&#x2013;1599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6038066</ArticleId><ArticleId IdType="pubmed">30018702</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong N, Zhang Z, Huang J, Chen C, Zhang Z, Jia M, Xiong J, Liu X, Wang F, Cao X, et al. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther. 2011;18(4):394&#x2013;402. doi: 10.1038/gt.2010.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gt.2010.152</ArticleId><ArticleId IdType="pubmed">21107440</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung TH, Hsu SC, Wu SH, Hsiao JK, Lin CP, Yao M, Huang DM. Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease. Nanoscale. 2018;10(6):2998&#x2013;3007. doi: 10.1039/C7NR06976F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7NR06976F</ArticleId><ArticleId IdType="pubmed">29372743</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Qiu Y, Qing Y, Xu J, Dai W, Hu X, Wu X. Synergistic effect of electric stimulation and mesenchymal stem cells against Parkinson's disease. Aging (Albany NY) 2020;12(16):16062&#x2013;16071. doi: 10.18632/aging.103477.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103477</ArticleId><ArticleId IdType="pmc">PMC7485716</ArticleId><ArticleId IdType="pubmed">32836217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghahari L, Safari M, Rahimi Jaberi K, Jafari B, Safari K, Madadian M. Mesenchymal stem cells with granulocyte colony-stimulating factor reduce stress oxidative factors in Parkinson's disease. Iran Biomed J. 2020;24(2):89&#x2013;98. doi: 10.29252/ibj.24.2.89.</Citation><ArticleIdList><ArticleId IdType="doi">10.29252/ibj.24.2.89</ArticleId><ArticleId IdType="pmc">PMC6984711</ArticleId><ArticleId IdType="pubmed">31677610</ArticleId></ArticleIdList></Reference><Reference><Citation>Bantubungi K, Blum D, Cuvelier L, Wislet-Gendebien S, Rogister B, Brouillet E, Schiffmann SN. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease. Mol Cell Neurosci. 2008;37(3):454&#x2013;470. doi: 10.1016/j.mcn.2007.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2007.11.001</ArticleId><ArticleId IdType="pubmed">18083596</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayat AH, Saeidikhoo S, Ebrahimi V, Mesgar S, Joneidi M, Soltani R, Aghajanpour F, Mohammadzadeh I, Torabi A, Abdollahifar MA, et al. Bilateral striatal transplantation of human olfactory stem cells ameliorates motor function, prevents necroptosis-induced cell death and improves striatal volume in the rat model of Huntington's disease. J Chem Neuroanat. 2021;112:101903. doi: 10.1016/j.jchemneu.2020.101903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2020.101903</ArticleId><ArticleId IdType="pubmed">33278568</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Lv H, Huang S, Tan H, Zhang Y, Li H. Bone marrow mesenchymal stem cells can improve the motor function of a Huntington's disease rat model. Neurol Res. 2011;33(3):331&#x2013;337. doi: 10.1179/016164110X12816242542571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164110X12816242542571</ArticleId><ArticleId IdType="pubmed">21513650</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossignol J, Fink KD, Crane AT, Davis KK, Bombard MC, Clerc S, Bavar AM, Lowrance SA, Song C, Witte S, et al. Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number. Stem Cell Res Ther. 2015;6(1):9. doi: 10.1186/scrt545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/scrt545</ArticleId><ArticleId IdType="pmc">PMC4429666</ArticleId><ArticleId IdType="pubmed">25971780</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossignol J, Boyer C, L&#xe9;v&#xe8;que X, Fink KD, Thinard R, Blanchard F, Dunbar GL, Lescaudron L. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes. Behav Brain Res. 2011;217(2):369&#x2013;378. doi: 10.1016/j.bbr.2010.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2010.11.006</ArticleId><ArticleId IdType="pubmed">21070819</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu-Taeger L, Stricker-Shaver J, Arnold K, Bambynek-Dziuk P, Novati A, Singer E, Lourhmati A, Fabian C, Magg J, Riess O, et al. Intranasal administration of mesenchymal stem cells ameliorates the abnormal dopamine transmission system and inflammatory reaction in the R6/2 mouse model of Huntington disease. Cells. 2019;8:6. doi: 10.3390/cells8060595.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8060595</ArticleId><ArticleId IdType="pmc">PMC6628278</ArticleId><ArticleId IdType="pubmed">31208073</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbaz EM, Helmy HS, El-Sahar AE, Saad MA, Sayed RH. Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington's disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/&#x3b2;-catenin signalling pathways. Neurochem Int. 2019;131:104548. doi: 10.1016/j.neuint.2019.104548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2019.104548</ArticleId><ArticleId IdType="pubmed">31539560</ArticleId></ArticleIdList></Reference><Reference><Citation>Linares GR, Chiu CT, Scheuing L, Leng Y, Liao HM, Maric D, Chuang DM. Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease. Exp Neurol. 2016;281:81&#x2013;92. doi: 10.1016/j.expneurol.2016.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.04.003</ArticleId><ArticleId IdType="pubmed">27085395</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicaise C, Mitrecic D, Pochet R. Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells. Neuropathol Appl Neurobiol. 2011;37(2):179&#x2013;188. doi: 10.1111/j.1365-2990.2010.01124.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2010.01124.x</ArticleId><ArticleId IdType="pubmed">20846186</ArticleId></ArticleIdList></Reference><Reference><Citation>Forostyak S, Jendelova P, Kapcalova M, Arboleda D, Sykova E. Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis. Cytotherapy. 2011;13(9):1036&#x2013;1046. doi: 10.3109/14653249.2011.592521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14653249.2011.592521</ArticleId><ArticleId IdType="pubmed">21736505</ArticleId></ArticleIdList></Reference><Reference><Citation>Canzi L, Castellaneta V, Navone S, Nava S, Dossena M, Zucca I, Mennini T, Bigini P, Parati EA. Human skeletal muscle stem cell antiinflammatory activity ameliorates clinical outcome in amyotrophic lateral sclerosis models. Mol Med. 2012;18(1):401&#x2013;411. doi: 10.2119/molmed.2011.00123.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2011.00123</ArticleId><ArticleId IdType="pmc">PMC3356418</ArticleId><ArticleId IdType="pubmed">22076467</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconi S, Bonaconsa M, Scambi I, Squintani GM, Rui W, Turano E, Ungaro D, D'Agostino S, Barbieri F, Angiari S, et al. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. Neuroscience. 2013;248:333&#x2013;343. doi: 10.1016/j.neuroscience.2013.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.05.034</ArticleId><ArticleId IdType="pubmed">23727509</ArticleId></ArticleIdList></Reference><Reference><Citation>Uccelli A, Milanese M, Principato MC, Morando S, Bonifacino T, Vergani L, Giunti D, Voci A, Carminati E, Giribaldi F, et al. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis. Mol Med. 2012;18(1):794&#x2013;804. doi: 10.2119/molmed.2011.00498.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2011.00498</ArticleId><ArticleId IdType="pmc">PMC3409288</ArticleId><ArticleId IdType="pubmed">22481270</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursch F, Rath KJ, Sarikidi A, B&#xf6;selt S, Kefalakes E, Osmanovic A, Thau-Habermann N, Kl&#xf6;&#xdf; S, K&#xf6;hl U, Petri S. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Tissue Eng Regen Med. 2019;13(4):649&#x2013;663. doi: 10.1002/term.2846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/term.2846</ArticleId><ArticleId IdType="pubmed">30811816</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x158;eho&#x159;ov&#xe1; M, Vargov&#xe1; I, Forostyak S, Vackov&#xe1; I, Turnovcov&#xe1; K, Kupcov&#xe1; Skaln&#xed;kov&#xe1; H, Vodi&#x10d;ka P, Kubinov&#xe1; &#x160;, Sykov&#xe1; E, Jendelov&#xe1; P. A combination of intrathecal and intramuscular application of human mesenchymal stem cells partly reduces the activation of necroptosis in the spinal cord of SOD1(G93A) rats. Stem Cells Transl Med. 2019;8(6):535&#x2013;547. doi: 10.1002/sctm.18-0223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.18-0223</ArticleId><ArticleId IdType="pmc">PMC6525562</ArticleId><ArticleId IdType="pubmed">30802001</ArticleId></ArticleIdList></Reference><Reference><Citation>Boucherie C, Sch&#xe4;fer S, Lavand'homme P, Maloteaux JM, Hermans E. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res. 2009;87(9):2034&#x2013;2046. doi: 10.1002/jnr.22038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22038</ArticleId><ArticleId IdType="pubmed">19267424</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, Suzuki M. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS) Exp Neurol. 2016;277:275&#x2013;282. doi: 10.1016/j.expneurol.2016.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.01.008</ArticleId><ArticleId IdType="pmc">PMC4762214</ArticleId><ArticleId IdType="pubmed">26775178</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YA, Lu CH, Ke CC, Chiu SJ, Jeng FS, Chang CW, Yang BH, Liu RS. Mesenchymal stem cell-derived exosomes ameliorate Alzheimer's disease pathology and improve cognitive deficits. Biomedicines. 2021;9:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8225157</ArticleId><ArticleId IdType="pubmed">34073900</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Contreras M, Thakor AS. Human adipose tissue-derived mesenchymal stem cells and their extracellular vesicles modulate lipopolysaccharide activated human microglia. Cell Death Discov. 2021;7(1):98. doi: 10.1038/s41420-021-00471-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00471-7</ArticleId><ArticleId IdType="pmc">PMC8110535</ArticleId><ArticleId IdType="pubmed">33972507</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahangard Y, Monfared H, Moradi A, Zare M, Mirnajafi-Zadeh J, Mowla SJ. Therapeutic effects of transplanted exosomes containing mir-29b to a rat model of Alzheimer's disease. Front Neurosci. 2020;14:564. doi: 10.3389/fnins.2020.00564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00564</ArticleId><ArticleId IdType="pmc">PMC7314926</ArticleId><ArticleId IdType="pubmed">32625049</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai L, Shen H, Sheng Y, Guan Q. ADMSC Exo-MicroRNA-22 improve neurological function and neuroinflammation in mice with Alzheimer's disease. J Cell Mol Med. 2021;25(15):7513&#x2013;7523. doi: 10.1111/jcmm.16787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16787</ArticleId><ArticleId IdType="pmc">PMC8335682</ArticleId><ArticleId IdType="pubmed">34250722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Lim H, Lee D, Choi SJ, Oh W, Yang YS, Oh JS, Hwang HH, Jeon HB. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model. Sci Rep. 2018;8(1):354. doi: 10.1038/s41598-017-18542-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18542-0</ArticleId><ArticleId IdType="pmc">PMC5762817</ArticleId><ArticleId IdType="pubmed">29321508</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SS, Jia J, Wang Z. Mesenchymal stem cell-derived extracellular vesicles suppresses iNOS expression and ameliorates neural impairment in Alzheimer's disease mice. J Alzheimers Dis. 2018;61(3):1005&#x2013;1013. doi: 10.3233/JAD-170848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170848</ArticleId><ArticleId IdType="pubmed">29254100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Ban JJ, Yang S, Im W, Kim M. The exosome of adipose-derived stem cells reduces &#x3b2;-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease. Brain Res. 2018;1691:87&#x2013;93. doi: 10.1016/j.brainres.2018.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.03.034</ArticleId><ArticleId IdType="pubmed">29625119</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuda T, Oki K, Ochiya T. Potential application of extracellular vesicles of human adipose tissue-derived mesenchymal stem cells in Alzheimer's disease therapeutics. Methods Mol Biol. 2015;1212:171&#x2013;181. doi: 10.1007/7651_2014_98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/7651_2014_98</ArticleId><ArticleId IdType="pubmed">25085563</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K, Oki K, Takeshita F, Sakai Y, Kuroda M, Ochiya T. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep. 2013;3:1197. doi: 10.1038/srep01197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep01197</ArticleId><ArticleId IdType="pmc">PMC3561625</ArticleId><ArticleId IdType="pubmed">23378928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Yang G. Bone marrow mesenchymal stem cells-derived exosomes reduce A&#x3b2; deposition and improve cognitive function recovery in mice with Alzheimer's disease by activating sphingosine kinase/sphingosine-1-phosphate signaling pathway. Cell Biol Int. 2021;45(4):775&#x2013;784. doi: 10.1002/cbin.11522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11522</ArticleId><ArticleId IdType="pubmed">33300254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Lee D, Lim H, Choi SJ, Oh W, Yang YS, Chang JH, Jeon HB. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease. Biochem Biophys Res Commun. 2018;504(4):933&#x2013;940. doi: 10.1016/j.bbrc.2018.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.09.012</ArticleId><ArticleId IdType="pubmed">30224067</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong WP, Yao WQ, Wang B, Liu K. BMSCs-exosomes containing GDF-15 alleviated SH-SY5Y cell injury model of Alzheimer's disease via AKT/GSK-3&#x3b2;/&#x3b2;-catenin. Brain Res Bull. 2021;177:92&#x2013;102. doi: 10.1016/j.brainresbull.2021.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2021.09.008</ArticleId><ArticleId IdType="pubmed">34536520</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques CR, Pereira-Sousa J, Teixeira FG, Sousa RA, Teixeira-Castro A, Salgado AJ. Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease. Cytotherapy. 2021;23(10):894&#x2013;901. doi: 10.1016/j.jcyt.2021.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2021.04.002</ArticleId><ArticleId IdType="pubmed">34059421</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahendru D, Jain A, Bansal S, Malik D, Dhir N, Sharma AR, Sarma P, Prakash A, Nahar U, Bhatia A, et al. Neuroprotective effect of bone marrow-derived mesenchymal stem cell secretome in 6-OHDA-induced Parkinson's disease. Regen Med. 2021;16(10):915&#x2013;930. doi: 10.2217/rme-2021-0018.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/rme-2021-0018</ArticleId><ArticleId IdType="pubmed">34553608</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wang Z, Xing H, Wang Y, Guo Y. Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease. Mol Ther Nucleic Acids. 2021;23:1334&#x2013;1344. doi: 10.1016/j.omtn.2021.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2021.01.022</ArticleId><ArticleId IdType="pmc">PMC7920810</ArticleId><ArticleId IdType="pubmed">33717653</ArticleId></ArticleIdList></Reference><Reference><Citation>Chierchia A, Chirico N, Boeri L, Raimondi I, Riva GA, Raimondi MT, Tunesi M, Giordano C, Forloni G, Albani D. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine. Eur J Pharm Biopharm. 2017;121:113&#x2013;120. doi: 10.1016/j.ejpb.2017.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpb.2017.09.014</ArticleId><ArticleId IdType="pmc">PMC5656105</ArticleId><ArticleId IdType="pubmed">28965958</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira FG, Vila&#xe7;a-Faria H, Domingues AV, Campos J, Salgado AJ. Preclinical comparison of stem cells secretome and levodopa application in a 6-hydroxydopamine rat model of Parkinson's disease. Cells. 2020;9:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7072263</ArticleId><ArticleId IdType="pubmed">32012897</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Brandi J, Manfredi M, Scambi I, Schiaffino L, Merigo F, Turano E, Bonetti B, Marengo E, Cecconi D, et al. The anti-apoptotic effect of ASC-exosomes in an in vitro ALS model and their proteomic analysis. Cells. 2019;8:9. doi: 10.3390/cells8091087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8091087</ArticleId><ArticleId IdType="pmc">PMC6770878</ArticleId><ArticleId IdType="pubmed">31540100</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Scambi I, Peroni D, Potrich V, Boschi F, Benati D, Bonetti B, Mariotti R. Exosome derived from murine adipose-derived stromal cells: neuroprotective effect on in vitro model of amyotrophic lateral sclerosis. Exp Cell Res. 2016;340(1):150&#x2013;158. doi: 10.1016/j.yexcr.2015.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2015.12.009</ArticleId><ArticleId IdType="pubmed">26708289</ArticleId></ArticleIdList></Reference><Reference><Citation>Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, Tetta C, Camussi G. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE. 2010;5(7):e11803. doi: 10.1371/journal.pone.0011803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011803</ArticleId><ArticleId IdType="pmc">PMC2910725</ArticleId><ArticleId IdType="pubmed">20668554</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Turano E, Scambi I, Busato A, Bontempi P, Virla F, Schiaffino L, Marzola P, Bonetti B, Mariotti R. ASC-exosomes ameliorate the disease progression in SOD1(G93A) murine model underlining their potential therapeutic use in human ALS. Int J Mol Sci. 2020;21:10. doi: 10.3390/ijms21103651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103651</ArticleId><ArticleId IdType="pmc">PMC7279464</ArticleId><ArticleId IdType="pubmed">32455791</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamp&#xe0; C, Alvino A, Magatti M, Silini AR, Cardinale A, Paldino E, Fusco FR, Parolini O. Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease. J Cell Mol Med. 2019;23(2):1581&#x2013;1592. doi: 10.1111/jcmm.14113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14113</ArticleId><ArticleId IdType="pmc">PMC6349233</ArticleId><ArticleId IdType="pubmed">30585395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J, Choi SJ, Kwon H, Yun HJ, Lee JM, et al. Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase 1 clinical trial. Alzheimers Dement (N Y) 2015;1(2):95&#x2013;102. doi: 10.1016/j.trci.2015.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2015.06.007</ArticleId><ArticleId IdType="pmc">PMC5975048</ArticleId><ArticleId IdType="pubmed">29854930</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, Lee JI, Chang JW, Park S, Kim ST, et al. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial. Alzheimers Res Ther. 2021;13(1):154. doi: 10.1186/s13195-021-00897-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00897-2</ArticleId><ArticleId IdType="pmc">PMC8439008</ArticleId><ArticleId IdType="pubmed">34521461</ArticleId></ArticleIdList></Reference><Reference><Citation>Duma C, Kopyov O, Kopyov A, Berman M, Lander E, Elam M, Arata M, Weiland D, Cannell R, Caraway C, et al. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients. Mol Biol Rep. 2019;46(5):5257&#x2013;5272. doi: 10.1007/s11033-019-04983-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-019-04983-5</ArticleId><ArticleId IdType="pubmed">31327120</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl Res. 2010;155(2):62&#x2013;70. doi: 10.1016/j.trsl.2009.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2009.07.006</ArticleId><ArticleId IdType="pubmed">20129486</ArticleId></ArticleIdList></Reference><Reference><Citation>Carstens M, Haq I, Martinez-Cerrato J, Dos-Anjos S, Bertram K, Correa D. Sustained clinical improvement of Parkinson's disease in two patients with facially-transplanted adipose-derived stromal vascular fraction cells. J Clin Neurosci. 2020;81:47&#x2013;51. doi: 10.1016/j.jocn.2020.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.09.001</ArticleId><ArticleId IdType="pubmed">33222965</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Olivieri C, Pastore I, Marasso R, Madon E. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(3):158&#x2013;161. doi: 10.1080/14660820310014653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310014653</ArticleId><ArticleId IdType="pubmed">13129802</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, Mareschi K, Ferrero I, Miglioretti M, Stecco A, Servo S, Carriero A, Monaco F, Fagioli F. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study. Cytotherapy. 2012;14(1):56&#x2013;60. doi: 10.3109/14653249.2011.613929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14653249.2011.613929</ArticleId><ArticleId IdType="pubmed">21954839</ArticleId></ArticleIdList></Reference><Reference><Citation>Siwek T, Jezierska-Wo&#x17a;niak K, Maksymowicz S, Barczewska M, Sowa M, Badowska W, Maksymowicz W. Repeat administration of bone marrow-derived mesenchymal stem cells for treatment of amyotrophic lateral sclerosis. Med Sci Monit. 2020;26:e927484. doi: 10.12659/MSM.927484.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.927484</ArticleId><ArticleId IdType="pmc">PMC7737405</ArticleId><ArticleId IdType="pubmed">33301428</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykov&#xe1; E, Rychmach P, Drahor&#xe1;dov&#xe1; I, Konr&#xe1;dov&#xe1; &#x160;, R&#x16f;&#x17e;i&#x10d;kov&#xe1; K, Vo&#x159;&#xed;&#x161;ek I, Forostyak S, Homola A, Bojar M. Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of phase I/IIa clinical trial. Cell Transplant. 2017;26(4):647&#x2013;658. doi: 10.3727/096368916X693716.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368916X693716</ArticleId><ArticleId IdType="pmc">PMC5661219</ArticleId><ArticleId IdType="pubmed">27938483</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, et al. Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a clinical trials. JAMA Neurol. 2016;73(3):337&#x2013;344. doi: 10.1001/jamaneurol.2015.4321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.4321</ArticleId><ArticleId IdType="pubmed">26751635</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HY, Kim H, Oh KW, Oh SI, Koh SH, Baik W, Noh MY, Kim KS, Kim SH. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study. Stem Cells. 2014;32(10):2724&#x2013;2731. doi: 10.1002/stem.1770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1770</ArticleId><ArticleId IdType="pubmed">24966156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J, Choi SJ, Kwon H, Yun HJ, Lee JM. Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase 1 clinical trial. Alzheimer's Dementia: Transl Res Clin Interv. 2015;1(2):95&#x2013;102. doi: 10.1016/j.trci.2015.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2015.06.007</ArticleId><ArticleId IdType="pmc">PMC5975048</ArticleId><ArticleId IdType="pubmed">29854930</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z, Gao F. Stem cell challenges in the treatment of neurodegenerative disease. CNS Neurosci Ther. 2012;18(2):142&#x2013;148. doi: 10.1111/j.1755-5949.2011.00239.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1755-5949.2011.00239.x</ArticleId><ArticleId IdType="pmc">PMC6493553</ArticleId><ArticleId IdType="pubmed">22070610</ArticleId></ArticleIdList></Reference><Reference><Citation>Shariati A, Nemati R, Sadeghipour Y, Yaghoubi Y, Baghbani R, Javidi K, Zamani M, Hassanzadeh A. Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier. Eur J Cell Biol. 2020;99(6):151097. doi: 10.1016/j.ejcb.2020.151097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2020.151097</ArticleId><ArticleId IdType="pubmed">32800276</ArticleId></ArticleIdList></Reference><Reference><Citation>Urrutia DN, Caviedes P, Mardones R, Minguell JJ, Vega-Letter AM, Jofre CM. Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: an approach for their use in neural regeneration therapies. PLoS ONE. 2019;14(3):e0213032. doi: 10.1371/journal.pone.0213032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0213032</ArticleId><ArticleId IdType="pmc">PMC6437714</ArticleId><ArticleId IdType="pubmed">30856179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahani-Nahayati M, Shariati A, Mahmoodi M, Olegovna Zekiy A, Javidi K, Shamlou S, Mousakhani A, Zamani M, Hassanzadeh A. Stem cell in neurodegenerative disorders; an emerging strategy. Int J Dev Neurosci. 2021;81(4):291&#x2013;311. doi: 10.1002/jdn.10101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jdn.10101</ArticleId><ArticleId IdType="pubmed">33650716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanzadeh A, Altajer AH, Rahman HS, Saleh MM, Bokov DO, Abdelbasset WK, Marofi F, Zamani M, Yaghoubi Y, Yazdanifar M. Mesenchymal stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy. Front Cell Develop Biol. 2021;9:8. doi: 10.3389/fcell.2021.686453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.686453</ArticleId><ArticleId IdType="pmc">PMC8311597</ArticleId><ArticleId IdType="pubmed">34322483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanzadeh A, Shamlou S, Yousefi N, Nikoo M, Verdi J. Genetically-modified stem cell in regenerative medicine and cancer therapy; a new era. Curr Gene Ther. 2022;22(1):23&#x2013;39. doi: 10.2174/1566523221666210707125342.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566523221666210707125342</ArticleId><ArticleId IdType="pubmed">34238158</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HN, Shin JY, Kim DY, Lee JE, Lee PH. Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in Parkinsonian models. J Tissue Eng. 2021;12:20417314211004816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013923</ArticleId><ArticleId IdType="pubmed">33854750</ArticleId></ArticleIdList></Reference><Reference><Citation>Senthilkumar S, Venugopal C, Parveen S, Shobha K, Rai KS, Kutty BM, Dhanushkodi A. Remarkable migration propensity of dental pulp stem cells towards neurodegenerative milieu: an in vitro analysis. Neurotoxicology. 2020;81:89&#x2013;100. doi: 10.1016/j.neuro.2020.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2020.08.006</ArticleId><ArticleId IdType="pubmed">32905802</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalani A, Tyagi A, Tyagi N. Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol. 2014;49(1):590&#x2013;600. doi: 10.1007/s12035-013-8544-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8544-1</ArticleId><ArticleId IdType="pmc">PMC3951279</ArticleId><ArticleId IdType="pubmed">23999871</ArticleId></ArticleIdList></Reference><Reference><Citation>Venugopal C, Shamir C, Senthilkumar S, Babu JV, Sonu PK, Nishtha KJ, Rai KS, Dhanushkodi A. Dosage and passage dependent neuroprotective effects of exosomes derived from rat bone marrow mesenchymal stem cells: an in vitro analysis. Curr Gene Ther. 2017;17(5):379&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366415</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Zhao S-Z. Mesenchymal stem cells: potential role in corneal wound repair and transplantation. World J Stem Cells. 2014;6(3):296&#x2013;304. doi: 10.4252/wjsc.v6.i3.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v6.i3.296</ArticleId><ArticleId IdType="pmc">PMC4131271</ArticleId><ArticleId IdType="pubmed">25126379</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X, Liu Y, Han Q, Jia M, Liao L, Qi M, Zhao RC. Injured microenvironment directly guides the differentiation of engrafted Flk-1+ mesenchymal stem cell in lung. Exp Hematol. 2007;35(9):1466&#x2013;1475. doi: 10.1016/j.exphem.2007.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2007.05.012</ArticleId><ArticleId IdType="pubmed">17637496</ArticleId></ArticleIdList></Reference><Reference><Citation>Katuchova J, Tothova T, Iannaccone SF, Toporcer T, Harvanova D, Hildebrand T, Kilik R, Bacenkova D, Frohlichova L, Rosocha J. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells. J Surg Res. 2012;178(1):188&#x2013;195. doi: 10.1016/j.jss.2012.02.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2012.02.028</ArticleId><ArticleId IdType="pubmed">22480834</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco SJ, Rameshwar P. Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies. Biologics. 2008;2(4):699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2727904</ArticleId><ArticleId IdType="pubmed">19707450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DY, Choi SH, Lee JS, Kim HJ, Kim HN, Lee JE, Shin JY, Lee PH. Feasibility and efficacy of intra-arterial administration of embryonic stem cell derived-mesenchymal stem cells in animal model of Alzheimer's disease. J Alzheimers Dis. 2020;76(4):1281&#x2013;1296. doi: 10.3233/JAD-200026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200026</ArticleId><ArticleId IdType="pubmed">32597802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzicka J, Kulijewicz-Nawrot M, Rodrigez-Arellano JJ, Jendelova P, Sykova E. Mesenchymal stem cells preserve working memory in the 3xTg-AD mouse model of Alzheimer's disease. Int J Mol Sci. 2016;17(2):152. doi: 10.3390/ijms17020152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17020152</ArticleId><ArticleId IdType="pmc">PMC4783886</ArticleId><ArticleId IdType="pubmed">26821012</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves AF, Camargo C, Premer C, Hare JM, Baumel BS, Pinto M. Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease. Exp Neurol. 2021;341:113706. doi: 10.1016/j.expneurol.2021.113706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2021.113706</ArticleId><ArticleId IdType="pubmed">33757765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Lee JK, Lee H, Shin JW, Carter JE, Sakamoto T, Jin HK, Bae JS. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci Lett. 2010;481(1):30&#x2013;35. doi: 10.1016/j.neulet.2010.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2010.06.045</ArticleId><ArticleId IdType="pubmed">20600610</ArticleId></ArticleIdList></Reference><Reference><Citation>Matchynski-Franks JJ, Pappas C, Rossignol J, Reinke T, Fink K, Crane A, Twite A, Lowrance SA, Song C, Dunbar GL. Mesenchymal stem cells as treatment for behavioral deficits and neuropathology in the 5xFAD mouse model of Alzheimer's disease. Cell Transplant. 2016;25(4):687&#x2013;703. doi: 10.3727/096368916X690818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368916X690818</ArticleId><ArticleId IdType="pubmed">26850119</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae JS, Jin HK, Lee JK, Richardson JC, Carter JE. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-&#x3b2; deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease. Curr Alzheimer Res. 2013;10(5):524&#x2013;531. doi: 10.2174/15672050113109990027.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/15672050113109990027</ArticleId><ArticleId IdType="pubmed">23036020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee NK, Park SE, Kwon SJ, Shim S, Byeon Y, Kim JH, Na DL, Chang JW. Agouti related peptide secreted via human mesenchymal stem cells upregulates proteasome activity in an Alzheimer's disease model. Sci Rep. 2017;7:39340. doi: 10.1038/srep39340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep39340</ArticleId><ArticleId IdType="pmc">PMC5209736</ArticleId><ArticleId IdType="pubmed">28051110</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Qiu Y, Qing Y, Xu J, Dai W, Hu X, Wu X. Synergistic effect of electric stimulation and mesenchymal stem cells against Parkinson's disease. Aging. 2020;12(16):16062&#x2013;16071. doi: 10.18632/aging.103477.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103477</ArticleId><ArticleId IdType="pmc">PMC7485716</ArticleId><ArticleId IdType="pubmed">32836217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YR, Lai PL, Chien Y, Lee PH, Lai YH, Ma HI, Shiau CY, Wang KC. Improvement of impaired motor functions by human dental exfoliated deciduous teeth stem cell-derived factors in a rat model of Parkinson's disease. Int J Mol Sci. 2020;21:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7312764</ArticleId><ArticleId IdType="pubmed">32471263</ArticleId></ArticleIdList></Reference><Reference><Citation>Cova L, Armentero M-T, Zennaro E, Calzarossa C, Bossolasco P, Busca G, Lambertenghi Deliliers G, Polli E, Nappi G, Silani V, et al. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res. 2010;1311:12&#x2013;27. doi: 10.1016/j.brainres.2009.11.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.11.041</ArticleId><ArticleId IdType="pubmed">19945443</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HJ, Lee PH, Bang OY, Lee G, Ahn YH. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson&#x2019;s disease. J Neurochem. 2008;107(1):141&#x2013;151. doi: 10.1111/j.1471-4159.2008.05589.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05589.x</ArticleId><ArticleId IdType="pubmed">18665911</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchez G, Senseb&#xe9; L, Vourch P, Garreau L, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard J-C, Chalon S. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem Int. 2008;52(7):1332&#x2013;1342. doi: 10.1016/j.neuint.2008.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2008.02.003</ArticleId><ArticleId IdType="pubmed">18372079</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao YX, He BP, Tay SSW. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. J Neuroimmunol. 2009;216(1):39&#x2013;50. doi: 10.1016/j.jneuroim.2009.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.09.003</ArticleId><ArticleId IdType="pubmed">19819031</ArticleId></ArticleIdList></Reference><Reference><Citation>Salama M, Sobh M, Emam M, Abdalla A, Sabry D, El-Gamal M, Lotfy A, El-Husseiny M, Sobh M, Shalash A. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease. Exp Ther Med. 2017;13(3):976&#x2013;982. doi: 10.3892/etm.2017.4073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2017.4073</ArticleId><ArticleId IdType="pmc">PMC5403256</ArticleId><ArticleId IdType="pubmed">28450929</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, Kushida Y, Wakao S, Tadokoro K, Nomura E, Omote Y, Takemoto M, Hishikawa N, Ohta Y, Dezawa M, et al. Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):17102. doi: 10.1038/s41598-020-74216-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74216-4</ArticleId><ArticleId IdType="pmc">PMC7554047</ArticleId><ArticleId IdType="pubmed">33051552</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, Ferrero I, Mazzini L, Madon E, Fagioli F. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008;31(3):395&#x2013;405. doi: 10.1016/j.nbd.2008.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.05.016</ArticleId><ArticleId IdType="pubmed">18586098</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Hou Z, Yang H, Meng M, Li P, Zou Q, Yang L, Chen Y, Chai H, Zhong H, et al. Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model. Cell Tissue Res. 2014;357(3):571&#x2013;582. doi: 10.1007/s00441-014-1903-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-014-1903-z</ArticleId><ArticleId IdType="pubmed">24906288</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossignol J, Fink K, Davis K, Clerc S, Crane A, Matchynski J, Lowrance S, Bombard M, Dekorver N, Lescaudron L, et al. Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's disease. Stem Cells. 2014;32(2):500&#x2013;509. doi: 10.1002/stem.1508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1508</ArticleId><ArticleId IdType="pubmed">23939879</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu TT, Su FJ, Feng YQ, Liu B, Li MY, Liang FY, Li G, Li XJ, Zhang Y, Cai ZQ, et al. Mesenchymal stem cells alleviate AQP-4-dependent glymphatic dysfunction and improve brain distribution of antisense oligonucleotides in BACHD mice. Stem Cells. 2020;38(2):218&#x2013;230. doi: 10.1002/stem.3103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.3103</ArticleId><ArticleId IdType="pubmed">31648394</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin EM, Reza BA, Morteza BR, Maryam MM, Ali M, Zeinab N. Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration. Neurol Res. 2008;30(10):1086&#x2013;1090. doi: 10.1179/174313208X327955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/174313208X327955</ArticleId><ArticleId IdType="pubmed">18768110</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink KD, Rossignol J, Crane AT, Davis KK, Bombard MC, Bavar AM, Clerc S, Lowrance SA, Song C, Lescaudron L, et al. Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis. Stem Cell Res Ther. 2013;4(5):130. doi: 10.1186/scrt341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/scrt341</ArticleId><ArticleId IdType="pmc">PMC3854759</ArticleId><ArticleId IdType="pubmed">24456799</ArticleId></ArticleIdList></Reference><Reference><Citation>Edalatmanesh MA, Matin MM, Neshati Z, Bahrami AR, Kheirabadi M. Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum. Neurol Res. 2010;32(2):166&#x2013;172. doi: 10.1179/174313209X409025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/174313209X409025</ArticleId><ArticleId IdType="pubmed">19570323</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Wang C, Wang X, Xu S. Therapeutic effects of transplantation of As-MiR-937-expressing mesenchymal stem cells in murine model of Alzheimer's disease. Cell Physiol Biochem. 2015;37(1):321&#x2013;330. doi: 10.1159/000430356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000430356</ArticleId><ArticleId IdType="pubmed">26316079</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wu X, Qu X, Wang X, Luo C, Li L, Zhang K. The effect of triggering receptor expressed by myeloid cells 2 modified bone marrow mesenchymal stem cells on Alzheimer's disease-mouse model. Ann Clin Lab Sci. 2019;49(1):23&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">30814074</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Zhou Y, Zhang R, Wu K, Lu Y, Li Y, Duan R, Yao Y, Zhu D, Jia Y. MicroRNA Let-7f-5p promotes bone marrow mesenchymal stem cells survival by targeting caspase-3 in Alzheimer disease model. Front Neurosci. 2018;12:333. doi: 10.3389/fnins.2018.00333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00333</ArticleId><ArticleId IdType="pmc">PMC5972183</ArticleId><ArticleId IdType="pubmed">29872375</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla-Porras AR, Arevalo-Arbelaez A, Alzate-Restrepo JF, Velez-Pardo C, Jimenez-Del-Rio M. PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine-induced apoptosis: potential therapeutic strategy in Parkinson's disease. Cytotherapy. 2018;20(1):45&#x2013;61. doi: 10.1016/j.jcyt.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2017.09.011</ArticleId><ArticleId IdType="pubmed">29079356</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Chang C, Zhang JW, Gao XQ. Alternation of proteins in brain of Parkinson's disease model rats after the transplantation of TH-NTN gene modified bone marrow mesenchymal stem cells. Zhonghua Yi Xue Za Zhi. 2012;92(33):2353&#x2013;2356.</Citation><ArticleIdList><ArticleId IdType="pubmed">23158567</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Xu H, Jiang Y, Deng W, Wu Z, Xiang H, Sun P, Xie J. The effect of lentivirus-mediated PSPN genetic engineering bone marrow mesenchymal stem cells on Parkinson's disease rat model. PLoS ONE. 2014;9(8):e105118. doi: 10.1371/journal.pone.0105118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105118</ArticleId><ArticleId IdType="pmc">PMC4132064</ArticleId><ArticleId IdType="pubmed">25118697</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui G-H, Guo H-D, Li H, Zhai Y, Gong Z-B, Wu J, Liu J-S, Dong Y-R, Hou S-X, Liu J-R. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease. Immunity Ageing. 2019;16:10. doi: 10.1186/s12979-019-0150-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-019-0150-2</ArticleId><ArticleId IdType="pmc">PMC6515654</ArticleId><ArticleId IdType="pubmed">31114624</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan R, Rabea AA, Ragae A, Sabry D. The prospective role of mesenchymal stem cells exosomes on circumvallate taste buds in induced Alzheimer's disease of ovariectomized albino rats: (light and transmission electron microscopic study) Arch Oral Biol. 2020;110:104596. doi: 10.1016/j.archoralbio.2019.104596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archoralbio.2019.104596</ArticleId><ArticleId IdType="pubmed">31734542</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes-Pinheiro B, Anjo SI, Manadas B, Da Silva JD, Marote A, Behie LA, Teixeira FG, Salgado AJ. Bone marrow mesenchymal stem cells' secretome exerts neuroprotective effects in a Parkinson's disease rat model. Front Bioeng Biotechnol. 2019;7:294. doi: 10.3389/fbioe.2019.00294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2019.00294</ArticleId><ArticleId IdType="pmc">PMC6838134</ArticleId><ArticleId IdType="pubmed">31737616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chierchia A, Chirico N, Boeri L, Raimondi I, Riva GA, Raimondi MT, Tunesi M, Giordano C, Forloni G, Albani D. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine. Eur J Pharma Biopharm. 2017;121:113&#x2013;120. doi: 10.1016/j.ejpb.2017.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpb.2017.09.014</ArticleId><ArticleId IdType="pmc">PMC5656105</ArticleId><ArticleId IdType="pubmed">28965958</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira FG, Vila&#xe7;a-Faria H, Domingues AV, Campos J, Salgado AJ. Preclinical comparison of stem cells secretome and levodopa application in a 6-hydroxydopamine rat model of Parkinson's disease. Cells. 2020;9(2):315. doi: 10.3390/cells9020315.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020315</ArticleId><ArticleId IdType="pmc">PMC7072263</ArticleId><ArticleId IdType="pubmed">32012897</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira FG, Carvalho MM, Panchalingam KM, Rodrigues AJ, Mendes-Pinheiro B, Anjo S, Manadas B, Behie LA, Sousa N, Salgado AJ. Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson's disease. Stem Cells Transl Med. 2017;6(2):634&#x2013;646. doi: 10.5966/sctm.2016-0071.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2016-0071</ArticleId><ArticleId IdType="pmc">PMC5442797</ArticleId><ArticleId IdType="pubmed">28191785</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>